Incorporating Pharmacogenomics in Clinical Studies

Venue: Hyatt Regency Baltimore

Location: Baltimore, Maryland, United States

Event Date/Time: Sep 25, 2006 End Date/Time: Sep 26, 2006
Report as Spam


The Institute for International Research is proud to announce the only conference dedicated to understanding how to Incorporate Pharmacogenomics in Clinical Trials. Currently, 121 marketed drug labels contain pharmacogenomic information and this information is used as a clinical adjunct for selection, dosing of drugs, as well as the assessment drug safety. As the world of pharmaceutical clinical development constantly evolves with an increased focus on safety and efficacy, it is imperative to develop a pharmacogenomic strategy to improve the likelihood of the success of your clinical trial through a better understanding of the pharmacogenetics of the drug. This conference is specifically focused on bringing you the most recent case examples and practical tools for developing and validating pharmacogenomics assays, learning from clinical experiences and understanding regulatory guidelines for incorporating pharmacogenomics into your trial. Whether you design clinical trials, develop pharmacogenomic assays, or build strategies to comply with regulatory guidelines for pharmacogenomic data submissions you will benefit from this conference.